Terrestrial Bio, Inc.

Terrestrial Bio, formerly Vaxess Technologies, is a biotech company developing a proprietary temperature-stable microarray patch (MAP) and applicator platform for delivering next-generation therapeutics, initially focusing on GLP-1 treatments. Its needle-free patches are designed for self-administration, eliminate refrigeration and sharps, and provide rapid or sustained delivery. The company is expanding automated manufacturing and preparing its platform for clinical trials and commercialization of next-generation medicines.